Similar articles for PMID: 21570156

Year	Number of Results
1971	1
1980	1
1982	1
1983	2
1985	1
1986	1
1987	1
1988	1
1989	1
1991	2
1992	2
1993	2
1994	4
1996	4
1997	4
1998	8
1999	13
2000	16
2001	12
2002	18
2003	14
2004	10
2005	8
2006	10
2007	13
2008	16
2009	10
2010	14
2011	16
2012	9
2013	10
2014	16
2015	18
2016	21
2017	11
2018	26
2019	17
2020	19
2021	16
2022	14
2023	5
2024	0

1

Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.

van der Rhee JI, Krijnen P, Gruis NA, de Snoo FA, Vasen HFA, Putter H, Kukutsch NA, Bergman W. van der Rhee JI, et al. J Am Acad Dermatol. 2011 Aug;65(2):281-288. doi: 10.1016/j.jaad.2010.06.044. Epub 2011 May 12. J Am Acad Dermatol. 2011. PMID: 21570156

2

Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.

van der Rhee JI, de Snoo FA, Vasen HFA, Mooi WJ, Putter H, Gruis NA, Kukutsch NA, Bergman W. van der Rhee JI, et al. J Am Acad Dermatol. 2011 Aug;65(2):289-296. doi: 10.1016/j.jaad.2010.06.067. Epub 2011 May 12. J Am Acad Dermatol. 2011. PMID: 21570154 Free PMC article.

3

Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.

Goldstein AM, Struewing JP, Chidambaram A, Fraser MC, Tucker MA. Goldstein AM, et al. J Natl Cancer Inst. 2000 Jun 21;92(12):1006-10. doi: 10.1093/jnci/92.12.1006. J Natl Cancer Inst. 2000. PMID: 10861313

4

Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case-control study.

Potjer TP, van der Stoep N, Houwing-Duistermaat JJ, Konings IC, Aalfs CM, van den Akker PC, Ausems MG, Dommering CJ, van der Kolk LE, Maiburg MC, Spruijt L, Wagner A, Vasen HF, Hes FJ. Potjer TP, et al. BMC Res Notes. 2015 Jun 26;8:264. doi: 10.1186/s13104-015-1235-4. BMC Res Notes. 2015. PMID: 26111702 Free PMC article.

5

Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.

Helgadottir H, Tuominen R, Olsson H, Hansson J, Höiom V. Helgadottir H, et al. J Am Acad Dermatol. 2017 Nov;77(5):893-901. doi: 10.1016/j.jaad.2017.05.050. Epub 2017 Aug 14. J Am Acad Dermatol. 2017. PMID: 28818438

6

Surveillance of second-degree relatives from melanoma families with a CDKN2A germline mutation.

van der Rhee JI, Boonk SE, Putter H, Cannegieter SC, Flinterman LE, Hes FJ, de Snoo FA, Mooi WJ, Gruis NA, Vasen HF, Kukutsch NA, Bergman W. van der Rhee JI, et al. Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1771-7. doi: 10.1158/1055-9965.EPI-13-0130. Epub 2013 Jul 29. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23897584

7

CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.

Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J. Hashemi J, et al. Cancer Res. 2000 Dec 15;60(24):6864-7. Cancer Res. 2000. PMID: 11156381

8

Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.

Figl A, Thirumaran RK, Ugurel S, Gast A, Hemminki K, Kumar R, Schadendorf D. Figl A, et al. Arch Dermatol. 2007 Apr;143(4):495-9. doi: 10.1001/archderm.143.4.495. Arch Dermatol. 2007. PMID: 17438182

9

Clinical and histopathological features of malignant melanoma in germline CDKN2A mutation families.

Måsbäck A, Olsson H, Westerdahl J, Sandberg T, Borg A, Jonsson N, Ingvar C. Måsbäck A, et al. Melanoma Res. 2002 Dec;12(6):549-57. doi: 10.1097/00008390-200212000-00004. Melanoma Res. 2002. PMID: 12459644

10

Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.

Taylor NJ, Handorf EA, Mitra N, Avril MF, Azizi E, Bergman W, Bianchi-Scarrà G, Bishop DT, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, Friedman E, Gerdes AM, Ghiorzo P, Goldstein AM, Grazziotin TC, Hansson J, Hayward NK, Hocevar M, Höiom V, Holland EA, Ingvar C, Landi MT, Landman G, Larre-Borges A, Leachman SA, Mann GJ, Nagore E, Olsson H, Palmer J, Perić B, Pjanova D, Puig S, Schmid H, van der Stoep N, Tucker MA, Wadt KAW, Whitaker L, Yang XR, Newton Bishop JA, Gruis NA, Kanetsky PA; GenoMEL Consortium. Taylor NJ, et al. J Invest Dermatol. 2016 May;136(5):1066-1069. doi: 10.1016/j.jid.2016.01.009. Epub 2016 Jan 28. J Invest Dermatol. 2016. PMID: 26827760 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

354 results

Results by year